
Core Viewpoint - PACS Group, Inc. is facing a class action securities lawsuit due to alleged securities fraud that has adversely affected its investors [1][2]. Class Definition - The lawsuit aims to recover losses for investors who purchased PACS Group's common stock during its initial public offering on April 11, 2024, and those who acquired securities between April 11, 2024, and November 5, 2024 [2]. Case Details - The complaint alleges that PACS Group engaged in fraudulent activities, including: 1. Submitting false Medicare claims that accounted for over 100% of the company's operating and net income from 2020 to 2023 [3]. 2. Billing for unnecessary respiratory and sensory integration therapies to Medicare [3]. 3. Falsifying documentation related to licensure and staffing [3]. 4. Making materially misleading statements about the company's business and prospects [3]. Next Steps - Investors who suffered losses during the relevant timeframe have until January 13, 2025, to request appointment as lead plaintiff, although participation does not require this role [4]. Why Levi & Korsinsky - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions for shareholders and being recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [5].